Airway submucosal glands (SMGs) are facultative stem cell niches for the surface epithelium, but the phenotype of the SMG-derived progenitor cells remains unclear. In other organs, glandular myoepithelial cells (MECs) have been proposed to be multipotent progenitors for luminal cells. We sought to determine the developmental phase during which mouse tracheal glandular MECs are born and whether these MECs are progenitors for other cell phenotypes during SMG morphogenesis. To approach this question, we localized two MEC protein markers (a-smooth muscle actin [aSMA/ACTA2] and smooth muscle myosin heavy chain 11 [SMMHC/MYH11]) during various stages of SMG development (placode, elongation, branching, and differentiation) and used ACTA2-Cre ERT2 and MYH11-Cre ERT2 transgenic mice to fate map MEC-derived lineages during SMG morphogenesis. Both aSMAand SMMHC-expressing cells emerged early after placode formation and during the elongation phase of SMG development. Lineage tracing in newborn mice demonstrated that lineage-positive MECs are born at the tips of invading tubules during the elongation phase of gland development. Lineage-positive MECs born within the first 7 days after birth gave rise to the largest percentage of multipotent progenitors capable of contributing to myoepithelial, serous, mucous, and ductal cell lineages. Serial tamoxifen-induction of both Cre-driver lines demonstrated that lineage-positive multipotent MECs contribute to z 60% of glandular cells by 21 days after birth. In contrast, lineagetraced MECs did not contribute to cell types in the surface airway epithelium. These findings demonstrate that MECs born early during SMG morphogenesis are multipotent progenitors with the capacity to differentiate into other glandular cell types.
Submucosal glands are secretory structures in the proximal cartilaginous airways and are adversely affected in many hypersecretory lung diseases including cystic fibrosis, chronic bronchitis, and asthma. Although submucosal glands are known to be a stem cell niche in the proximal airway, little is known about how this niche is established during development and the phenotype of glandular progenitor cells. Using lineage tracing, we demonstrate that myoepithelial cells born early during glandular morphogenesis contribute to multiple lineages of the mature gland.
Airway submucosal glands (SMGs) are secretory structures found in the submucosa of large conducting airways and form a contiguous epithelium with the airway surface. SMGs in mice are limited to the proximal trachea, but in humans they are found throughout all levels of the cartilaginous airways. SMGs play important roles in airway innate immunity and secrete the majority of fluid, mucus, and antimicrobials into the large airways of most species (1, 2) . In mice, multipotent stem cells have been shown to exist within SMGs and to contribute to regeneration of the surface airway epithelium (SAE) after severe injury (3) (4) (5) (6) (7) . In diseases such as cystic fibrosis, asthma, chronic bronchitis, and other forms of chronic obstructive lung disease, SMG hypertrophy can lead to excessive or altered mucus production in the airway (2, 8, 9) , and these changes can also alter properties of the SMG stem cell niche (10) .
Fully developed SMGs are composed of ciliated ducts, collecting ducts, mucous tubules, and serous tubules. The cellular composition of ciliated ducts is similar to that of the surface airway epithelium and primarily includes basal and ciliated cells. Lysozyme-expressing serous cells and mucus-secreting cells are generally considered to be differentiated cell types that emerge later during SMG morphogenesis and line the serous and mucous tubules, respectively. Collecting ducts are composed of a nonciliated columnar cell type of poorly defined phenotype. Myoepithelial cells (MECs) line the outside of tubules within SMGs and express both alpha-smooth muscle actin (aSMA) and smooth muscle myosin heavy chain 11 (SMMHC).
Despite a large body of literature enhancing our understanding of progenitor cells on the airway surface (11) , there is fairly little known about the lineage relationships of SMG progenitors. The ducts of airway SMGs have historically been considered the sites at which SMG stem cells reside, based on the discovery of slowly cycling nucleotide label-retaining cells in this region and the existence of duct progenitors that are multipotent for SAE cell types (3-5, 12, 13) . However, others have found that glandular labelretaining cells, which are able to cycle after repeated injury and to retain multiple nucleotide labels, can reside deeper within SMG tubules (6, 7, 10) . Furthermore, isolated progenitors from mouse SMGs are multipotent for both glandular and surface airway epithelial cell types and have a greater regenerative capacity than SAE progenitors (6) . These studies emphasize an increased need to understand the progenitor cell phenotypes in SMGs.
The majority of mouse models used to study airway stem cells rely on injury to induce proliferation and cellular expansion (14) because of the low turnover rate of airway epithelia (15) . However, the field has also learned a significant amount about glandular stem cells by studying the earliest phases of SMG morphogenesis (16, 17) . In this context, SMG placodes, which are composed of primordial glandular stem cells, use Wnt signals to coordinate early stages of gland development and branching morphogenesis (18) (19) (20) (21) (22) (23) . Wnt signaling in adult mouse SMGs also appears to be a component of the stem cell niche, with slowly cycling label-retaining cells residing near glandular regions of increased Wnt signaling in myoepithelial and serous cells (6) . Interestingly, after severe airway injury, the first cycling SMG progenitors activate expression of two transgenic Wnt reporters that are also activated in primordial glandular stem cells during the placode phase of SMG morphogenesis (6) . Thus, regenerative aspects of the adult glandular stem cell niche may share biologic processes involved in glandular stem cell niche formation.
Lineage relationships during glandular morphogenesis have been most extensively studied in the mammary gland. In this context, the mammary gland MEC is considered to be a candidate multipotent stem cell that is closely related to the luminal basal cell (24) (25) (26) (27) . Interestingly, lineage tracing studies using the ACTA2-Cre ERT2 driver have demonstrated that mouse mammary MECs are long-lived, lineagerestricted progenitors of basal cells during pregnancy in vivo, but have the capacity to form all cellular components of the mammary gland when transplanted ex vivo (26) . Similarly, MECs of the lacrimal gland have also been suggested to have multipotent capacity for differentiation during development and repair after injury (28, 29) .
Given the conserved stem cell biology during development of SMGs and regenerative expansion of adult SMG progenitors after injury (6, 7) ) (31) were purchased from Jackson Laboratory (Bar Harbor, ME). After Cre-mediated recombination, ROSA-TG mice switch expression from a membrane-associated tdTomato to a membrane-associated EGFP. A second Cre-driver strain of mice Tg(Acta2-cre/ERT2)51Pcn (ACTA2-Cre ERT2 ) was also used (32) . Both male and female ACTA2-Cre
ERT2
:ROSA-TG doubletransgenic mice were evaluated. Only male MYH11-Cre
:ROSA-TG were used because the MYH11-Cre ERT2 transgene is on the Y-chromosome. Newborn ferret tracheas were obtained from the Iowa National Ferret Research and Resource Center.
Lineage Tracing Studies and Tissue Harvesting
Cre-mediated recombination was induced using a single injection (intraperitoneal) of tamoxifen suspended in corn oil (0.2 mg/dose for pups; 2 mg/kg for adults) or by serial gavages (0.2 mg/dose) every other day from birth to 18 days of age. Tracheas were harvested at various points up to 21 days, fixed in 4% paraformaldehyde at 4 8 C for 48 hours, and then embedded in optimal cutting temperature compound.
Histology, Immunofluorescent Localization, and Imaging
Frozen sections (8 mm) were postfixed in 4% paraformaldehyde for 20 minutes, washed in PBS, and then incubated in blocking buffer (PBS, 20% donkey serum, 0.3% Triton X-100, and 1 mM CaCl 2 ) for 1 hour. The primary antibodies, lectins, and dilutions used are indicated in Table E1 in the online supplement. Primary antibodies were applied to sections in blocking buffer containing 1% donkey serum overnight at 4 8 C. Slides were then washed in PBS and stained with secondary antibodies for 2 hours at room temperature (Table E1) . When paraffin sections were used (Lef-1 and Sox9 staining), antigen retrieval was performed after deparaffinization by boiling in citrate buffer for 5 minutes in a pressure cooker. The sections were then processed as described earlier. For lectin staining, frozen sections were first blocked with an Avidin/Biotin Blocking Kit (Vector Laboratories SP-2001) and then rinsed in PBS before incubation with the biotinylated-lectin and avidin-conjugatedfluorochrome, sequentially, for 30 minutes each. Slides were washed in PBS and then stained using 49,6-diamidino-2-phenylindole. Slides were mounted with ProLong Gold (P36930; Invitrogen, Carlsbad, CA). Fluorescent images were collected with a Zeiss LSM 700 linescanning confocal microscope (Carl Zeiss, Göttingen, Germany), and images were processed using Fiji-ImageJ.
Morphometric Analysis
All images were acquired with the same scope settings to ensure scales and thresholds were the same. The area of SMG structures was quantified using the area tool of ImageJ. Image analysis for the lineage tracing green fluorescent protein (GFP) reporter and cell type markers was performed using the MetaMorph Software's (Nashville, TN) Multi Wavelength Cell Scoring application with at least three sections 50 mm apart, evaluated for each animal. These values were averaged for animal/trachea and the N animals used to calculate means and SEM.
Gland Development Nomenclature and Definitions
We described our findings in the context of four phases of SMG development: phase 1 (placode): primordial gland placodes form in the SAE with no visible lumen; phase 2 (elongation), invagination of SMG buds with the formation of a lumen; phase 3 (branching), growing primary tubules begin to branch; phase 4 (differentiation), maturation of SMG mucous and serous tubules with differentiated phenotypes.
Results

MEC Phenotypes Emerge Very Early during Airway SMG Development
To evaluate the stage of SMG morphogenesis during which MECs are born, we localized two phenotypic markers (aSMA and SMMHC) of mature MECs during postnatal tracheal development in the mouse (Figure 1 ). During phase 1 of SMG morphogenesis at 0-3 days of age, epithelial aSMA expression was not observed in the placode and early invaginating buds ( Figure 1A ). In contrast, during elongation (phase 2) and early branching (phase 3), aSMA expression began to emerge on the periphery of tubules with visible lumens by 3-5 days of age ( Figures 1B and 1C) . By 21 days after birth, aSMA expression was observed around nearly all tubules ( Figure 1D) . A very similar developmental pattern of expression was also observed using immunofluorescent staining for SMMHC as a marker for MECs ( Figures 1E-1H ).
The Lef-1 transcription factor is highly expressed in early SMG progenitors during the placode and elongation phases (20) and is required for SMG development (i.e., Lef-1 knockout mice fail to develop SMGs) (18, 19, 21) . Mammary glands also require Lef-1 for development (33, 34) . Interestingly, Sox9 is also required for mammary gland morphogenesis, and lineage tracing studies demonstrate that Sox9 1 mammary progenitor cells give rise to both luminal and myoepithelial lineages (35) . However, Sox9 is only required for lineage commitment and proliferation of luminal, but not myoepithelial, cells of the mammary gland (35) . To better understand the phenotype of early aSMA 1 progenitors during SMG development, we colocalized Lef-1 and Sox9 with aSMA. In addition to mouse trachea, we also evaluated newborn ferret trachea, as this species has abundant tracheal SMG placodes at birth (22) . Lef-1 and Sox9 were highly expressed in epithelial cells of the placode, and aSMA 1 cells were absent in both species at this stage ( Figure E1 ). During the elongation phase, aSMA 1 cells emerged at the periphery of tubules in both species, and a subset of these cells was positive for Lef-1 and Sox9 ( Figure E1 ). These findings suggest that MECs born early during SMG development partially retain the phenotype of luminal progenitors, and thus MECs may be daughters of early luminal cells.
Lineage Tracing Demonstrates Early MEC Progenitors Dynamically Expand during Glandular Morphogenesis
To confirm the phases in which MEC arise during gland development and to evaluate whether early MEC lineages are multipotent, we performed lineage tracing with an ACTA2-Cre ERT2 driver on a ROSA-TG Cre-reporter background. This ACTA2-Cre ERT2 driver marked only SMG MECs in adult mice after tamoxifen injection ( Figure E2 ). Reasoning that the During the branching and differentiated phases of gland development, lineage-traced cells were observed with apical membranes that reached the lumen of tubules, as well as surrounding the basement membrane of tubules with morphology consistent with MECs ( Figures 2H-2J ). This finding suggests that MECs born early during gland morphogenesis may differentiate into other phenotypic lineages within SMGs.
Lineage-Traced MECs Express Basal Cell Markers during All Phases of Glandular Morphogenesis
Lineage tracing during development comes with caveats that relate to promoter specificity of the Cre-driver. For example, during the elongation phase of SMG morphogenesis, it is possible that the ACTA2 promoter is ectopically expressed in undifferentiated progenitors. Although this limitation of lineage tracing is difficult to completely disprove, one approach to support specificity of the Cre-driver is to localize other phenotypic markers of the cell type being mapped. MECs are thought to be phenotypically very similar to basal cells in multiple organs. Three common basal cell markers include p63, CK5, and CK14 (36) , and these markers are also expressed in all or a subset of MECs in mature SMGs (5, 6) . To this end, we colocalized GFP expression with p63, CK5, or CK14 during all phases of gland development in animals that were pulsed with tamoxifen at birth. Results from these experiments demonstrated that many of the ACTA2-Cre ERT2 lineage-traced cells also expressed p63, CK5, and CK14 during all phases of gland development in which lineage traced cells were observed ( Figure 3 ). During phase 1 (placode phase), all three basal cell markers were expressed in the absence of lineage-traced cells ( Figures  3A-3C ). During phase 2 (elongation phase), most lineage-traced cells expressed CK5 and CK14, whereas a subset of cells at the tips of the tubules expressed p63 (Figures 3D-3F ). Similar patterns of expression were observed during phase 3 (branching phase) and phase 4 (maturation phase) ( Figures 3G-3O ). These findings support the notion that early during gland development, newly born MECs retain a basal cell phenotype that is similar to that of primordial glandular stem cells found in the placode and that this phenotype is also retained in more mature MECs.
MEC Progenitors Give Rise to Other Glandular Cell Types during Development
To conclusively demonstrate that ACTA2-Cre ERT2 lineage-traced cells give rise to non-MEC lineages during SMGs morphogenesis, we evaluated the abundance of aSMA-positive and aSMAnegative glandular cells that expressed the GFP lineage marker (Figure 4 ). By 21 days postinduction, GFP expression was observed in luminal cells of tubules that lacked aSMA expression ( Figure 4A ). During early stages of gland development, tubules containing lineage-tagged aSMA-negative cells often lacked lumens, whereas during later stages of gland maturation, clear lumens could be observed ( Figure 4B ). At 3 days postinduction, z50% of aSMA 1 cells were also GFP-positive; this fraction declined to 25% by Day 21 ( Figure 4C ). This finding reflects two important points: First, a single injection of tamoxifen at birth was only effective in labeling half of the MECs born by 3 days of age, and second, z50% of MECs likely emerge after clearance of tamoxifen from newborn animals, based on the z50% drop in lineage tracing efficiency by 21 days of age. However, the percentage of GFP 1 cells that also expressed aSMA was 93% at Day 3 ( Figure 4D ); this demonstrated specificity of the ACAT2-Cre ERT2 driver, given that the percentage is well within the limits of morphometry for colocalization of two proteins in different cellular compartments (i.e., membrane-bound GFP and cytoplasmic aSMA). Interestingly, the percentage of GFP 1 cells that also expressed aSMA 1 declined to 67% at Day 21 postinduction ( Figure 4D ). Looking at these data an alternative way, the percentage of GFP 1 cells that lacked aSMA expression rose significantly (P , 0.0001) by fivefold between 3 and 21 days postlabeling ( Figure 4E) preferentially expand later during gland development.
MEC Progenitors Give Rise to Multiple Cell Types during SMG Development
The findings of ACTA2 lineage-labeled GFP 1 aSMA 2 cell types within developing SMGs suggests MECs can differentiate into phenotypically distinct cell types. To define these cell types, we colocalized the GFP lineage trace with markers of duct cells (Trop2), serous cells (lysozyme and Dolichos biflorus agglutinin [DBA] lectin), and mucus-producing cells (Ulex europaeus agglutinin I [UEA-1] lectin). UEA-1 has been previously shown to react with Muc5AC (37) . In adult SMGs, DBA and UEA-1 react with two distinct cellular compartments that morphologically appear to be serous and mucous tubules ( Figure E5 ). These phenotyping studies demonstrated the existence of GFP 1 lysozyme 1 ( Figure 5A ) and GFP Figure 5D ). Overall, these findings support the notion that MECs give rise to multiple distinct cellular populations during SMG development.
As one might expect, some of these serous and mucous tubules with a GFP 1 phenotype appeared clonal in origin ( Figures  5A and 5C ), suggesting an MEC progenitor had committed to form multiple cells within these tubules during development. Interestingly, not all GFP 1 cells were tdTomato 2 ( Figure 5 ), however, it should be noted that the transgenic animals used were homozygous for the ROSA-TG locus. The finding of GFP Further experiments using a confetti reporter would be needed to quantitatively assess the extent to which this occurs during morphogenesis of glandular tubules.
MEC Lineage-Positive and LineageNegative Progenitors Both Contribute to Gland Development
Fate mapping using lineage-restricted Credrivers comes with caveats. The most critical caveats are specificity of the promoters used to lineage-trace the target cell type and lineage tracing efficiency (38, 39) . To this end, we sought to validate our findings with a second MYH11-Cre ERT2 Cre-driver that efficiently marks MECs in adult SMGs ( Figures E7A and E7B ). Single tamoxifen dosing at birth in MYH11-Cre Figures E7C and E7D) .
To determine the lineage tracing efficiency and maximal contribution of lineage-positive progenitors to non-MEC lineages within 21-day SMGs, we performed gavage dosing of tamoxifen every other day from birth to 18 days of age, using both the ACTA2-Cre :ROSA-TG mice. Thus, using this serial induction protocol, the lineage tracing efficiency was z 95% using both Cre-drivers. As expected, this serial induction protocol gave rise to a larger percentage of SMG cells that were GFP 1 at 21 days (z60% for both Cre-drivers) ( Figure 6I ) as compared with the z20% GFP 1 cells observed in mice labeled once at birth ( Figure 4I) . Importantly, the percentage of SMG lineage-traced GFP1 cells that were aSMA 2 or SMMHC 2 was z50% for both Cre-drivers ( Figure 6K ), a value significantly higher than that observed after a single dose of tamoxifen at birth, using the ACTA2-Cre ERT2 driver (z33%; P , 0.0001 using Student's t test) ( Figure 4E ). These findings suggest that multipotent lineage-positive MECs and lineage-negative glandular progenitors both contribute to non-MEC cellular compartments during glandular development.
To narrow down the window in which multipotent MECs are born during gland development, we also performed timed single-dose pulse inductions with tamoxifen in ACTA2-Cre Figures 6B-6D and 6F-6H) . In most measurements quantified with both Cre-drivers, the every-other-day dosing of tamoxifen was significantly greater than single dosing at 3, 5, and 7 days for the percentage of GFP 1 SMG cells ( Figure 6I ), total number of GFP 1 cells per section ( Figure 6J) , and the percentage of GFP 1 cells that were aSMA 2 or SMMHC 2 ( Figure 6K ).
Importantly, there was no significant difference in the quantification of these three endpoints between the two Cre-drivers. Although the percentage of lineage-positive cells that adopted a aSMA 2 or SMMHC 
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Anderson, Lynch, and Engelhardt: Birth of Multipotent Glandular Myoepithelial Cellst test) ( Figure 6K) . Furthermore, the sum of the percentage of GFP 1 cells that were aSMA 2 or SMMHC 2 for 3-, 5-, and 7-day pulse induction points was z48% for both Cre-drivers ( Figure 6K ). This number was extremely close to the 50% achieved for this cellular phenotype, using every-otherday induction for 18 days ( Figure 6K ). Thus, we conclude that the majority of multipotent MEC progenitors are born during the 3-7-day postnatal period.
Discussion
MECs have been proposed to be potential progenitor cells of many glandular organs, including the mammary gland (25, 26, 40, 41) , salivary gland (42) , and lacrimal gland (28, 29) . However, even in the mammary gland, the most extensively studied of these organs, a debate remains as to whether basal cell-like MECs are unipotent or multipotent (25, 26, 40) . Much of the debate revolves around discrepancies between lineage tracing studies in vivo and ex vivo, using transplantation assays with isolated cell populations. For example, two studies demonstrate that mammary MECs and luminal cells are long-lived lineage-restricted progenitors during development, puberty, and pregnancy; however, transplantation assays with isolated mammary MECs have the capacity to self-renew and form whole mammary glands, whereas isolated luminal cells do not have this capacity (26, 40) . In contrast, Rios and colleagues demonstrated, using lineage tracing clonal analysis, that a subset of mammary MEC progenitors has the capacity to differentiate into luminal cells during development (25) . Similar to this later report, our findings demonstrate that earlyborn MECs can commit to forming multiple cell types during development of airway SMGs.
Using both aSMA and SMMHC MEC markers ( Figure 1 ) and ACTA2-Cre ERT2 lineage tracing (Figure 2 ), MECs first emerge after placode formation during the elongation phase when invading SMG tubules form lumens. Based on the design of our initial lineage tracing studies (i.e., single induction at birth), our data suggest that z50% of self-renewing glandular MECs emerge during the first few days of the neonatal period. This calculation is based on z50% lineage tracing efficiency at 3 days and the finding of fewer (z25%) lineagetagged aSMA 1 cells by 21 days (Figure 4C ). These lineage-positive cells and their descendents expanded 10-fold between 3 and 21 days of SMG development ( Figure 4H ; P , 0.001). Although it is difficult to estimate the bioavailability of tamoxifen in newborn mice after a single injection at z200 mg/kg (intraperitoneally), based on a 12-hour half-life of tamoxifen in serum after oral dosing to adult mice (43), we assume, at the high dose given in these studies, that it persists for 2-3 days. Interestingly, the percentage of 21- 1 , and p63 1 ). However, these data also support the existence of a second lineage-negative progenitor (i.e., not of MEC lineage, aSMA 2 , SMMHC 2 ) that contributes cells to the developing SMG. These lineage-negative progenitors likely also express Lef-1 and Sox9, as nearly all cells of the tubule express these transcription factors at this stage. However, because expression of basal cell markers during the elongation phase is not uniform, it is unclear whether lineage-negative progenitors express CK5 and/or CK14. (C) During branching and differentiation phases of SMG development, multipotent MECs can give rise to new MECs and differentiate into serous cells, mucous cells, and ductal cells. Although the lineage hierarchy of MEC progenitors remains unclear, timed pulse induction studies after birth suggest that both multipotent and unipotent MECs likely exist. Lineage-negative progenitors appear to have a lineage bias for differentiation into ductal cells and mucous cells, but less frequently differentiate into serous cells and MECs. The inverted triangles schematically show the relative lineage bias for differentiation of each progenitor population (red, most abundant; blue, least abundant). (D) Differentiation markers used in this study to define various cell types. mice (24.7 6 4.9%) ( Figure 4C ). These findings suggest that a self-renewing unipotent MEC progenitor likely emerges by z3-4 days after birth and may contribute to the majority of MECs in the 21-day gland.
The most conclusive evidence that a subset of MECs formed early during gland development are multipotent progenitors comes from the finding that lineage-positive aSMA-negative cells rose fivefold between 3 to 21 days postinduction at birth ( Figure 4E ). Interestingly, lineage-positive cells and their descendents constituted 50% of SMG tubular epithelia at 7 days postinduction, but this percentage dropped to 22% by 21 days (Figure 4I ), despite a 3.2-fold rise in the total number of GFP 1 glandular cells during this period ( Figure 4H ). Several potential explanations may account for these two seemingly disparate results. First, untraced MEC progenitors that emerge later during SMG development may contribute to a larger proportion of glandular epithelia. This would imply that the lineage-positive MECs born early during morphogenesis have a limited capacity for self-renewal and differentiation into other glandular cell types. Second, lineage-negative (non-MEC) progenitors may expand to form specific cellular compartments later during SMG development. Studies using multiple serial inductions and timed single-dose induction of ACTA2-Cre ERT2 and MYH11-Cre ERT2 driver mice suggest the later hypothesis is likely correct. The maximal contribution of lineage-positive MECs to all SMG cells was z60% for both Cre drivers when mice were induced every other day for 18 days ( Figure 6I ). Given that the lineage tracing efficiency in this multiple-dose study was z95% of aSMA 1 and SMMHC 1 MECs, these findings demonstrate that both lineage-positive and lineage-negative progenitors contribute to SMG development. Timed single-dose tamoxifen injections also suggest that the window for birth of multipotent MECs is highest between 3 and 7 days after birth ( Figure 6K ), assuming tamoxifen bioavailability from 3-and 5-day injection spans that period. Although we did not perform single-induction points past 7 days of age, one would predict that very few lineage-positive cells would have an aSMA 2 and SMMHC 2 phenotype when induction is performed past 9 days of age. These findings warrant further investigation to define the hierarchy of MEC and non-MEC glandular progenitors during gland morphogenesis.
Our findings provide evidence that ACTA2-expressing MECs born early during airway SMG morphogenesis are a selfrenewal progenitor capable of contributing to serous cell lineages ( Figure 5 ). However, other less abundant lineage-tagged cell types included Trop2-expressing and mucus-producing cells. Thus, one interpretation of these findings could be that lineage-positive multipotent MECs have a bias toward MEC and serous cell lineages, whereas lineage-negative glandular progenitors may primarily contribute to duct-and mucus-producing cellular lineages ( Figure 7 ). However, it should be noted that mucous tubules appear to not be fully formed by 21 days compared with adult SMGs (Figure E5 ). Trop2 1 cells of the gland duct have been demonstrated to have multipotent capacity for differentiation into surface airway epithelial cell types after injury (12) . Whether glandular MECs are precursors to duct cells in adult mice, and thus sit at the apex of the glandular progenitor cell hierarchy, remains to be determined. The formation of lineagetagged serous and mucous cell clusters within tubules ( Figures 5A and 5C and Figure E6 ) suggests that MEC-derived progenitors may commit toward various lineages and expand locally during SMG morphogenesis. However, it remains unclear whether MECs can directly differentiate into various glandular cell types or, rather, are directed toward a lineage-committed progenitor cell that lacks aSMA expression. The appearance of tightly packed lineage-tagged cell clusters that lack aSMA expression lends support to the later hypothesis (Figures 2Ciii, Dv, and Eviii; Figure 4B , upper; Figure E8 ). These tight cellular clusters that lack tubular structure are reminiscent of CK5 1 pods in the distal lung after severe lung injuries (44, 45) . These CK5
1 pods have been suggested to be composed of multipotent progenitors capable of distal lung repair after necrotizing influenza infection. Further phenotyping and additional lineage tracing studies are needed to definitively answer these questions, as they pertain to multipotent MECs.
In summary, we have shown using lineage tracing that multipotent MECs are born very early during airway gland morphogenesis and that these progenitor cells have the ability to form multiple luminal cell types that lack expression of MEC markers (Figure 7 ). Our data are also consistent with a self-renewing population of unipotent MECs that emerges during this same period. Importantly, our findings also support a lineage-independent progenitor cell population that is equally important for gland morphogenesis (Figure 7 ). Whether MECs of adult SMGs retain a multipotent capacity for differentiation during normal cellular turnover and disease-based glandular hypertrophy remains unclear. However, findings from this study suggest that further investigation into whether adult MECs have multipotent stem cell characteristics after airway injury is warranted. n Author disclosures are available with the text of this article at www.atsjournals.org.
